CO-TRIMOXAZOLE

This brand name is authorized in Estonia, France, Malta, New Zealand

Active ingredients

The drug CO-TRIMOXAZOLE contains a combination of these active pharmaceutical ingredients (APIs):

1 Trimethoprim UNII AN164J8Y0X - TRIMETHOPRIM

Trimethoprim is a dihydrofolate reductase inhibitor, inhibiting the conversion of bacterial dihydrofolic acid to tetrahydrofolic acid, required for the synthesis of some amino acids. Its effects are considerably greater on the cells of micro-organisms than on the mammalian cells. Read about Trimethoprim

2 Sulfamethoxazole UNII JE42381TNV - SULFAMETHOXAZOLE

Sulfamethoxazole competitively inhibits the utilisation of para-aminobenzoic acid in the synthesis of dihydrofolate by the bacterial cell resulting in bacteriostasis. Read about Sulfamethoxazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01EE01	Sulfamethoxazole and trimethoprim	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01E Sulfonamides and trimethoprim → J01EE Combinations of sulfonamides and trimethoprim, incl. derivatives
Discover more medicines within J01EE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1814745
Country: FR	Base de données publique des médicaments	Identifier(s): 67891013
Country: MT	Medicines Authority	Identifier(s): AA565/30102, AA565/35502, MA1317/01701
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4884